Holen Sie sich die Stockscreener-App
2.85
18.26%
0.44
Schlusskurs vom Vortag:
$2.41
Offen:
$2.48
24-Stunden-Volumen:
3.22M
Relative Volume:
3.71
Marktkapitalisierung:
$197.13M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-77.22M
KGV:
-1.6255
EPS:
-1.7533
Netto-Cashflow:
$-77.27M
1W Leistung:
+61.93%
1M Leistung:
+39.02%
6M Leistung:
-36.38%
1J Leistung:
+139.50%
1-Tages-Spanne:
$2.44
$2.875
1-Wochen-Bereich:
$1.77
$2.875
52-Wochen-Spanne:
$1.01
$7.80
Pepgen Inc Stock (PEPG) Company Profile
Firmenname
Pepgen Inc
Sektor
Branche
Telefon
703-456-8000
Adresse
1 MARINA PARK DRIVE, SUITE 900, BOSTON
Compare PEPG vs VRTX, REGN, ARGX, RVMD, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PEPG
Pepgen Inc
|
2.85 | 131.42M | 0 | -77.22M | -77.27M | -1.7533 |
VRTX
Vertex Pharmaceuticals Inc
|
496.07 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
784.36 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
865.04 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
205.15 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
348.27 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Pepgen Inc Stock (PEPG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-09 | Eingeleitet | Guggenheim | Buy |
| 2024-12-16 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-07-31 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-12-21 | Eingeleitet | H.C. Wainwright | Buy |
Pepgen Inc Aktie (PEPG) Neueste Nachrichten
PepGen Inc (PEPG) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
PepGen Inc (PEPG) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
PepGen Inc (PEPG) Cash Flow - TradingKey
Recover Investment Losses: Levi & Korsinsky Files Class Action Against PepGen Inc. (PEPG) - The National Law Review
PepGen Inc (PEPG) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
PepGen Inc (PEPG) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
PepGen Inc (PEPG) Income Statement - TradingKey
PepGen Inc (PEPG) Institutional Confidence - TradingKey
PepGen Inc (PEPG) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
PEPG|PepGen Inc|Price:1.890|Chg%:-0.040 - TradingKey
PepGen Inc (PEPG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Why PEPG, SGMO, PHR Are Among Top Premarket Losers Today - Stocktwits
PepGen (PEPG) Edges Lower, Holding Near Key Support ZonePut Flow Alert - dars.gov.et
PepGen Inc. (PEPG) Edges Higher as Stock Holds Above Key SupportVolume Weighted Price - dars.gov.et
PepGen Inc. (PEPG) Edges Higher, Tests Resistance After Modest GainHead and Shoulders - dars.gov.et
PepGen Q1 2026 Earnings: Narrower-than-Expected Loss Drives Shares HigherDebt Analysis Report - dars.gov.et
PepGen Inc. (PEPG) Q1 2026 Earnings: Narrower-than-expected loss drives positive stock reactionEarnings Cycle Report - dars.gov.et
PEPGPepGen Inc Latest SEC Filings - Finviz
PepGen Inc. (PEPG) Q1 2026 Earnings: Narrower-Than-Expected Loss as Biotech Advances PipelineEarnings Decline Risk - dars.gov.et
PEPG LAWSUIT ALERT: Levi & Korsinsky Notifies PepGen Inc. InvestorsLead Plaintiff Deadline August 8, 2025 - The National Law Review
PepGen Inc. (PEPG) Edges Higher as Biotech Stock Tests Key ResistanceGamma Squeeze - dars.gov.et
PepGen Inc. (PEPG) Investigation: Bronstein, Gewirtz & Grossman - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Is Investigating PepGen Inc. (PEPG) And Encourages Stockholders to Connect - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Encourages PepGen Inc. (PEPG) Investors to Inquire about Securities Investigation - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Is Investigating PepGen Inc. (PEPG) And Encourages Shareholders to Connect - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Price to sales forward of PepGen Inc. – NASDAQ:PEPG - TradingView
Enterprise value to revenue forward of PepGen Inc. – BOATS:PEPG - TradingView
Price to earnings forward of PepGen Inc. – BOATS:PEPG - TradingView
Price to book forward of PepGen Inc. – NASDAQ:PEPG - TradingView
Enterprise value to EBITDA forward of PepGen Inc. – BOATS:PEPG - TradingView
Enterprise value to EBIT forward of PepGen Inc. – NASDAQ:PEPG - TradingView
Class Action Lawsuit Filed: PepGen Inc. (PEPG)Join by August 8, 2025Contact Levi & Korsinsky - The National Law Review
PEPG Stockholders Have Opportunity to Lead PepGen Inc. Class Acti - The National Law Review
PEPG INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
PEPG SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
Did You Lose Money on PepGen Inc. (PEPG)? Levi & Korsinsky Urges Investors to Act Before August 8, 2025 - The National Law Review
Number of shareholders of PepGen Inc. – NASDAQ:PEPG - TradingView
Price to sales forward of PepGen Inc. – BOATS:PEPG - TradingView
PepGen Inc. Actuals & Estimates (NASDAQ:PEPG) - TradingView
PEPG Forecast — Price Target — Prediction for 2027 - TradingView
PepGen (PEPG) upgraded to buy: Here's what you should know - MSN
PepGen Inc. (PEPG) Edges Higher: Key Levels and Technical OutlookPercent Below MA - dars.gov.et
PepGen Inc. 8-K Filing: Annual Meeting Results, Nasdaq Listing, and Key Company Information for June 2026 - Minichart
PepGen (PEPG) loses 14.3% in 4 weeks, here's why a trend reversal may be around the corner - MSN
PepGen Shareholders Back Directors and KPMG at 2026 Meeting - TipRanks
PepGen (PEPG) director granted 34,000 options for RA Capital funds - Stock Titan
Form 4 PepGen Ltd For: 22 June By Investing.com - Investing.com South Africa
34K PepGen (PEPG) options awarded for RA Capital-managed accounts - Stock Titan
PepGen (PEPG) investors elect Class I directors and ratify KPMG as 2026 auditor - Stock Titan
PepGen (PEPG) awards director 34,000 options vesting by next meeting - Stock Titan
Finanzdaten der Pepgen Inc-Aktie (PEPG)
Umsatz
Nettogewinn
Free Cashflow
ENV
Pepgen Inc-Aktie (PEPG) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| STRECK PAUL | EVP, Head of R&D |
Mar 04 '26 |
Sale |
6.23 |
1,879 |
11,709 |
76,226 |
| Donnelly Noel | Chief Financial Officer |
Mar 04 '26 |
Sale |
6.23 |
2,084 |
12,988 |
111,603 |
| McArthur James G | President and CEO |
Mar 04 '26 |
Sale |
6.23 |
5,275 |
32,876 |
296,326 |
| Oxford Science Enterprises plc | Former 10% Owner |
Sep 30 '25 |
Buy |
3.20 |
200,000 |
640,000 |
4,955,388 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Sep 26 '25 |
Buy |
3.20 |
9,375,000 |
30,000,000 |
18,554,273 |
1.84%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):